SCHEMBL452603

SCHEMBL452603

C(=C/c1ccccc1)\COOC/C=C/c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.68
PAM P19021 1/20 0.50
MAOB P27338 3/20 0.48
HTR2A P28223 4/20 0.47
MAOA P21397 2/20 0.46
CA1 P00915 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP12 P39900 1/20 0.44
OPRM1 P35372 1/20 0.44
HTR2C P28335 1/20 0.42
HTR2B P41595 1/20 0.42
SIGMAR1 Q99720 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL452602 1.00 IDO1 (0.68) IDO1PAMMAOBHTR2AMAOA
SCHEMBL13957704 0.89 IDO1 (0.57) IDO1PAMMAOBHTR2AMAOA
SCHEMBL7923411 0.89 IDO1 (0.57) IDO1PAMMAOBHTR2AMAOA
SCHEMBL7923408 0.89 IDO1 (0.57) IDO1PAMMAOBHTR2AMAOA
SCHEMBL1657284 0.87 IDO1 (0.59) IDO1PAMMAOBHTR2AMAOA
SCHEMBL1657285 0.87 IDO1 (0.59) IDO1PAMMAOBHTR2AMAOA
SCHEMBL430934 0.85 IDO1 (0.68) IDO1PAMMAOBHTR2AHTR2C
SCHEMBL7514298 0.85 IDO1 (0.68) IDO1PAMMAOBHTR2AHTR2C
SCHEMBL430935 0.85 IDO1 (0.68) IDO1PAMMAOBHTR2AHTR2C
SCHEMBL11179703 0.85 IDO1 (0.57) IDO1PAMMAOBHTR2AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11597696-B2 Method for purifying polymerizable fluoromonomer by distillation CENTRAL GLASS COMPANY, LIMITED (JP) 2023-03-07 US disclosed
US-20210317065-A1 Method for Purifying Polymerizable Fluoromonomer by Distillation CENTRAL GLASS COMPANY, LIMITED (JP) 2021-10-14 US disclosed
US-9678425-B2 Polymerizable fluoromonomer, fluoropolymer, resist material, and method of pattern formation CENTRAL GLASS COMPANY, LIMITED (JP) 2017-06-13 US disclosed
US-9678426-B2 Polymerizable fluoromonomer, fluoropolymer, resist material, and method of pattern formation CENTRAL GLASS COMPANY, LIMITED (JP) 2017-06-13 US disclosed
US-9650451-B2 Fluorine-containing compounds and their polymers useful for anti-reflection film materials and resist compositions CENTRAL GLASS COMPANY, LIMITED (JP) 2017-05-16 US disclosed
US-9604891-B2 Methods for producing fluorine-containing hydroxyaldehyde, fluorine-containing propanediol, and fluorine-containing alcohol monomer CENTRAL GLASS COMPANY, LIMITED (JP) 2017-03-28 US disclosed
CN-104661998-B The compound comprising double (perfluoroalkyl group sulfonyl) methyl and the manufacture method of salt, employ its solid electrolyte film 中央硝子株式会社 2017-03-01 CN disclosed
US-9512070-B2 Method for producing compound containing BIS (perfluoroalkylsulfonyl) methyl group and salt thereof, and solid electrolyte membrane produced using same CENTRAL GLASS COMPANY, LIMITED (JP) 2016-12-06 US disclosed
US-9488914-B2 Fluorine-containing sulfonic acid salt, fluorine-containing sulfonic acid salt resin, resist composition, and pattern forming method using same CENTRAL GLASS COMPANY, LIMITED (JP) 2016-11-08 US disclosed
US-20150361026-A1 Methods for Producing Fluorine-Containing Hydroxyaldehyde, Fluorine-Containing Propanediol, and Fluorine-Containing Alcohol Monomer CENTRAL GLASS COMPANY, LIMITED (JP) 2015-12-17 US disclosed
EP-1720067-A1 TOP COAT COMPOSITION Central Glass Company, Limited (JP) 2006-11-08 EP disclosed
US-7125943-B2 Fluorine containing compounds with unsaturated ether or ester groups CENTRAL GLASS COMPANY, LIMITED (JP) 2006-10-24 US disclosed
US-7122292-B2 Lactone compounds, lactone-containing monomers, their polymers, resist compositions using same, and processes for forming patterns using same CENTRAL GLASS COMPANY, LIMITED (JP) 2006-10-17 US disclosed
US-20060135744-A1 Fluorinated cyclic compound, polymerizable fluoromonomer, fluoropolymer, resist material comprising the same, and method of forming pattern with the same CENTRAL GLASS COMPANY LIMITED (JP) 2006-06-22 US disclosed
US-20060057489-A1 Lactone compounds, lactone-containing monomers, their polymers, resist compositions using same, and processes for forming patterns using same CENTRAL GLASS COMPANY, LIMITED (JP) 2006-03-16 US disclosed
US-20050250898-A1 Top coat composition CENTRAL GLASS COMPANY, LIMITED (JP) 2005-11-10 US disclosed
US-6858760-B2 Fluorine-containing cyclic compounds, fluorine-containing polymerizable monomers, fluorine-containing polymers resist compositions and patterning method CENTRAL GLASS COMPANY, LIMITED (JP) 2005-02-22 US disclosed
US-20040225159-A1 Fluorine-containing cyclic compounds, fluorine-containing polymerizable monomers, fluorine-containing polymers resist compositions and patterning method CENTRAL GLASS COMPANY, LTD. (JP) 2004-11-11 US disclosed
US-20040192867-A1 Fluorine-containing compounds, fluorine-containing polymerizable monomers, fluorine-containing polymers, dissolution inhibitors, and resist compositions CENTRAL GLASS COMPANY, LIMITED (JP) 2004-09-30 US disclosed
US-20040106755-A1 Fluorine containing compounds with unsaturated ether or ester groups CENTRAL GLASS COMPANY, LIMITED (JP) 2004-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317065-A1 Method for Purifying Polymerizable Fluoromonomer by Distillation AFF1, AFF4, AFF2 IDO1 3896/4885PAM 901/4885MAOB 48/4885
US-20060135744-A1 Fluorinated cyclic compound, polymerizable fluoromonomer, fluoropolymer, resist material comprising the same, and method of forming pattern with the same PFAS, AFF1, FUBP1 IDO1 4283/4885PAM 1093/4885MAOB 1790/4885
US-20150361026-A1 Methods for Producing Fluorine-Containing Hydroxyaldehyde, Fluorine-Containing Propanediol, and Fluorine-Containing Alcohol Monomer ADH1A, ADH1C, ADH5 IDO1 2979/4885PAM 1303/4885MAOB 78/4885
US-11597696-B2 Method for purifying polymerizable fluoromonomer by distillation AFF1, AFF4, AFF2 IDO1 3896/4885PAM 901/4885MAOB 48/4885
US-20040225159-A1 Fluorine-containing cyclic compounds, fluorine-containing polymerizable monomers, fluorine-containing polymers resist compositions and patterning method AFF1, FPR1, AFF2 IDO1 1886/4885PAM 982/4885MAOB 990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.